CORONAVIRUS/Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
07/20/2021 07:01 PM
Taipei, July 20 (CNA) Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![COVID-19 death rate exceeding 0.1 percent a warning: health minister]()
COVID-19 death rate exceeding 0.1 percent a warning: health ministerHealth Minister Chen Shih-chung (陳時中) said Thursday that the COVID-19 death rate in Taiwan exceed 0.1 percent over the past two days, a figure he characterized as a warning.05/26/2022 11:36 PM![Self-health management rule for migrant workers to be relaxed from Friday]()
Self-health management rule for migrant workers to be relaxed from FridayEffective from Friday, migrant workers arriving in Taiwan will no longer have to observe the seven-day self-health management protocol that follows mandatory quarantine, the ...05/26/2022 11:33 PM![Taiwan COVID-19 News Briefs: May 26]()
Taiwan COVID-19 News Briefs: May 26Taiwan on Thursday reported 81,907 new COVID-19 cases, down slightly from the day before, and 104 deaths from the disease, according to the Central Epidemic Command Center (CECC).05/26/2022 09:27 PM
Latest
- Politics
China's provocation against Taiwan 'deeply destabilizing:' Blinken
05/27/2022 12:42 AM - Culture
France selected as theme country at Taipei book fair for the fourth time
05/27/2022 12:26 AM - Society
COVID-19 death rate exceeding 0.1 percent a warning: health minister
05/26/2022 11:36 PM - Society
Self-health management rule for migrant workers to be relaxed from Friday
05/26/2022 11:33 PM - Society
Taiwan freedivers compete under 'Taiwan' at Caribbean Cup after protesting
05/26/2022 10:09 PM